Amgen : AMGN

All Amgen Articles

720 Articles

Jon C. Ogg | Jul 20, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with…

Chris Lange | Jul 13, 2020 at 9:43 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Biotechs

The June 30 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Jun 25, 2020 at 9:46 AM EDT

Short Sellers Run for Cover From Major Biotechs

The June 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jun 10, 2020 at 10:01 AM EDT

Major Biotechs Have Short Sellers on the Run

The May 29 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | May 28, 2020 at 9:37 AM EDT

Major Biotechs See More Targeted Short Sellers

The May 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | May 12, 2020 at 9:36 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The April 30 short interest data has been compared with the previous report, and short interest in most of these…

247sarah | May 6, 2020 at 9:30 AM EDT

Why Borrowing $8.5 Billion Won’t Impact Apple Stock

Apple borrowed $8.5 billion Monday in a four-part bond deal. Why? Because right now, money is cheap.

Chris Lange | Apr 27, 2020 at 8:47 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Apr 13, 2020 at 9:40 AM EDT

Big Biotechs Scare Off Short Sellers

The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Jon C. Ogg | Mar 30, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More

Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and…

Chris Lange | Mar 25, 2020 at 9:45 AM EDT

Major Biotechs Get Mixed Message on Short Interest

The March 13 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Mar 11, 2020 at 9:13 AM EDT

Big Biotechs Have Short Sellers Confused

The February 28 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Feb 27, 2020 at 8:35 AM EST

Major Biotechs Have Short Sellers Confused

The February 14 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Feb 20, 2020 at 7:35 AM EST

15 Top ESG Stocks That Look Undervalued for 2020

With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks…

Chris Lange | Feb 12, 2020 at 8:45 AM EST

Biotech Short Sellers Focus on a Couple Favorites

The January 31 data has been compared with the previous report, and short interest in most of these selected biotech…

1 … 10 11 12 13 14 … 48

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs Have Short Sellers on the Run

Major Biotechs See More Targeted Short Sellers

Short Sellers Raise the Stakes in Major Biotechs

Why Borrowing $8.5 Billion Won’t Impact Apple Stock

Short Sellers Grow More Selective on Major Biotechs

Big Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More

Major Biotechs Get Mixed Message on Short Interest

Big Biotechs Have Short Sellers Confused

Major Biotechs Have Short Sellers Confused

15 Top ESG Stocks That Look Undervalued for 2020

Biotech Short Sellers Focus on a Couple Favorites

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Short Sellers Can’t Make Up Their Minds on Big Biotechs

Short Sellers Run for Cover From Major Biotechs

Major Biotechs Have Short Sellers on the Run

Major Biotechs See More Targeted Short Sellers

Short Sellers Raise the Stakes in Major Biotechs

Why Borrowing $8.5 Billion Won’t Impact Apple Stock

Short Sellers Grow More Selective on Major Biotechs

Big Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More

Major Biotechs Get Mixed Message on Short Interest

Big Biotechs Have Short Sellers Confused

Major Biotechs Have Short Sellers Confused

15 Top ESG Stocks That Look Undervalued for 2020

Biotech Short Sellers Focus on a Couple Favorites

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Featured Reads

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.